Fosbait 500mg tablet contains active components such as Lanthanum carbonate. It is a medication used to treat hyperphosphatemia, characterized by elevated levels of phosphate in the blood, often seen in patients with chronic kidney disease (CKD). It may be used to manage phosphate levels in patients with end-stage renal disease who require hemodialysis or peritoneal dialysis, along with dietary restrictions and other phosphate binders. In some cases, hyperphosphatemia can occur in individuals with rare genetic disorders or certain metabolic conditions that affect phosphate metabolism. It may be considered in such cases to help control phosphate levels. This medication should be prescribed and monitored by a healthcare professional. Individuals who have had an allergic or hypersensitivity reaction to Fosbait 500mg tablet or its components should not use this medication. It should not be used in patients with gastrointestinal obstruction because it may not be absorbed properly or could exacerbate the obstruction. It should not be crushed or chewed. Therefore, individuals who have difficulty swallowing tablets and cannot take them as directed should not use this medication. Individuals with severe bowel conditions, such as inflammatory bowel disease (IBD) or bowel obstructions, may be at an increased risk of complications when using this medication. Discussing the potential risks and benefits with a healthcare provider in such cases is important. It is generally recommended to use calcium supplements concurrently with Fosbait 500mg tablet with close monitoring by a healthcare professional.